Occupational learning tool developer NovoEd, based on research at Stanford, has been bought by Devonshire Investors after raising $4.8m of series A capital in 2014.

Stanford-Start X Fund has put its weight behind Oh My Green's seed round, which also attracted a host of venture capital firms.

Oxford Nanopore has secured $66m from Amgen, after the latter’s subsidiary Decode Genetics used the spinout’s technology to sequence hundreds of human genomes.

The cell biology technology developer, based on UC Berkeley research, took its total funding to almost $220m in a Nikon-led round that included fellow strategic backer Varian.

Karolinska Institute spinout Palette Life Sciences will add three medical products based on Nestlé’s intellectual property to its existing program targeting pain suffered during gynaecological procedures.

Mercia Technologies has returned to back Locate Bio's pursuit of orthopaedic therapies based on research at University of Nottingham.

Datum Invest has led a $15.3m round for educational game platform Kahoot, which is the result of research at Norwegian University of Technology and Science.

University of Bristol Enterprise Fund II has backed antibiotic diagnostics developer Vitamica, which spun out of the university’s school of physics in January 2018.

University of Kentucky will lead a consortium of academic institutions participating in a US government-funded commercialisation hub intended to accelerate biomedical research.

University of Notre Dame and Indiana University have both backed a $9m seed fund aimed at supporting local businesses in life sciences, health IT and agricultural biosciences.